BFM
EVH icon

Boothbay Fund Management’s Evolent Health EVH Stock Holding History

Boothbay Fund Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$108K Sell
47,227
-121,656
-72% -$386K ﹤0.01% 1868
2025
Q4 		$676K Buy
168,883
+137,821
+444% +$766K 0.01% 985
2025
Q3 		$263K Buy
+31,062
New +$301K ﹤0.01% 1515
2020
Q1 		– Sell
-93,620
Closed -$847K – 908
2019
Q4 		$847K Buy
+93,620
New +$761K 0.07% 357

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boothbay Fund Management's EVH Position: Q1 2026 in Review

Boothbay Fund Management reduced its Evolent Health (EVH) stake by 72% in Q1 2026, selling an estimated $386K and leaving 47,227 shares worth $108K. The position accounts for ﹤0.01% of the portfolio, ranked #1868.

Boothbay Fund Management first reported a position in EVH in Q4 2019 and has held it in 4 quarters since. The position peaked at $847K in Q4 2019. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Boothbay Fund Management held 47,227 shares of Evolent Health worth $108K as of Q1 2026.
  • Boothbay Fund Management sold 121,656 Evolent Health shares in Q1 2026, an estimated $386K.
  • Evolent Health made up ﹤0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1868 holding.
  • Boothbay Fund Management first reported a position in Evolent Health in Q4 2019 and has held it in 4 quarters since.
  • Boothbay Fund Management's Evolent Health position peaked at $847K in Q4 2019.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.